NKTR Nektar Therapeutics
Nektar Therapeutics (NKTR) Institutional Ownership
What the institutions did with NKTR last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| FMR LLC | 5.1M | 14.1% |
| Two Seas Capital LP | 3.1M | 8.6% |
| BlackRock, Inc. | 2.9M | 8.2% |
| BVF INC/IL | 2.4M | 6.7% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.5M | 4.2% |
| TWO SIGMA INVESTMENTS, LP | 1.2M | 3.3% |
| Vestal Point Capital, LP | 1.0M | 2.8% |
| MORGAN STANLEY | 936.6K | 2.6% |
| STATE STREET CORP | 909.7K | 2.5% |
| GEODE CAPITAL MANAGEMENT, LLC | 881.3K | 2.5% |
| Prosight Management, LP | 810.0K | 2.3% |
| ARMISTICE CAPITAL, LLC | 724.0K | 2.0% |
| GILDER GAGNON HOWE & CO LLC | 600.9K | 1.7% |
| MILLENNIUM MANAGEMENT LLC | 478.1K | 1.3% |
| BRAIDWELL LP | 473.6K | 1.3% |
| Sofinnova Investments, Inc. | 471.8K | 1.3% |
| Woodline Partners LP | 470.9K | 1.3% |
| ORBIMED ADVISORS LLC | 465.3K | 1.3% |
| UBS Group AG | 428.4K | 1.2% |
| EMERALD ADVISERS, LLC | 390.2K | 1.1% |
| LORD, ABBETT & CO. LLC | 381.6K | 1.1% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 348.5K | 1.0% |
| DAFNA Capital Management LLC | 318.4K | 0.9% |
| NORTHERN TRUST CORP | 308.5K | 0.9% |
| Deep Track Capital, LP | 300.0K | 0.8% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| BlackRock, Inc. | Increased | 692.7K | 2.9M | +2.2M |
| Two Seas Capital LP | Increased | 2.0M | 3.1M | +1.1M |
| FMR LLC | Increased | 4.3M | 5.1M | +764.7K |
| Vestal Point Capital, LP | Increased | 285.0K | 1.0M | +715.0K |
| STATE STREET CORP | Increased | 244.7K | 909.7K | +665.0K |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 346.8K | 881.3K | +534.5K |
| Invesco Ltd. | Reduced | 567.5K | 79.9K | -487.6K |
| CITADEL ADVISORS LLC | Reduced | 513.5K | 159.7K | -353.8K |
| GILDER GAGNON HOWE & CO LLC | Increased | 271.8K | 600.9K | +329.1K |
| Deep Track Capital, LP | New | 0 | 300.0K | +300.0K |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 1.2M | 1.5M | +299.8K |
| MORGAN STANLEY | Increased | 659.4K | 936.6K | +277.2K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 72.5K | 348.5K | +276.0K |
| TWO SIGMA INVESTMENTS, LP | Increased | 930.7K | 1.2M | +271.3K |
| Qube Research & Technologies Ltd | Reduced | 390.7K | 130.5K | -260.2K |
| BRAIDWELL LP | Increased | 222.7K | 473.6K | +250.9K |
| BARCLAYS PLC | Increased | 32.4K | 262.4K | +230.0K |
| NORTHERN TRUST CORP | Increased | 78.6K | 308.5K | +229.9K |
| JPMORGAN CHASE & CO | Reduced | 240.1K | 22.1K | -218.0K |
| Patient Square Capital LP | Sold Out | 210.0K | 0 | -210.0K |
| ORBIMED ADVISORS LLC | Increased | 275.0K | 465.3K | +190.3K |
| BVF INC/IL | Reduced | 2.6M | 2.4M | -168.5K |
| DAFNA Capital Management LLC | Increased | 165.2K | 318.4K | +153.2K |
| DEUTSCHE BANK AG\ | Increased | 91.7K | 239.8K | +148.2K |
| ARMISTICE CAPITAL, LLC | Increased | 578.0K | 724.0K | +146.0K |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.